Yoshiaki Katano

3.7k total citations
148 papers, 2.9k citations indexed

About

Yoshiaki Katano is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Yoshiaki Katano has authored 148 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Hepatology, 69 papers in Epidemiology and 36 papers in Surgery. Recurrent topics in Yoshiaki Katano's work include Hepatitis C virus research (67 papers), Liver Disease Diagnosis and Treatment (50 papers) and Hepatitis B Virus Studies (38 papers). Yoshiaki Katano is often cited by papers focused on Hepatitis C virus research (67 papers), Liver Disease Diagnosis and Treatment (50 papers) and Hepatitis B Virus Studies (38 papers). Yoshiaki Katano collaborates with scholars based in Japan, United States and China. Yoshiaki Katano's co-authors include Hidemi Goto, Isao Nakano, Masatoshi Ishigami, Yoshiki Hirooka, Kazuhiko Hayashi, Akihiro Ito, Yoshihide Fukuda, Takashi Honda, Hidenori Toyoda and Eizaburo Ohno and has published in prestigious journals such as Blood, The Journal of Immunology and Gastroenterology.

In The Last Decade

Yoshiaki Katano

141 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiaki Katano Japan 30 1.4k 1.2k 848 676 373 148 2.9k
Hitoshi Takagi Japan 32 1.3k 1.0× 1.5k 1.2× 657 0.8× 963 1.4× 649 1.7× 212 3.5k
Arndt Weinmann Germany 32 1.1k 0.8× 1.7k 1.4× 716 0.8× 691 1.0× 602 1.6× 161 3.3k
Jeong Heo South Korea 35 1.2k 0.9× 1.6k 1.3× 946 1.1× 998 1.5× 633 1.7× 188 3.9k
Kazuaki Inoue Japan 28 1.1k 0.8× 1.1k 0.9× 504 0.6× 632 0.9× 686 1.8× 107 2.8k
Michio Imawari Japan 34 1.4k 1.1× 1.6k 1.3× 632 0.7× 544 0.8× 573 1.5× 175 3.7k
Mylène Sebagh France 36 1.6k 1.2× 2.5k 2.0× 752 0.9× 1.4k 2.0× 330 0.9× 129 3.7k
Jane Collier United Kingdom 32 2.4k 1.8× 2.2k 1.8× 531 0.6× 930 1.4× 632 1.7× 91 4.3k
Carlo Fabris Italy 29 1.7k 1.2× 1.5k 1.2× 430 0.5× 478 0.7× 299 0.8× 160 3.0k
Masatoshi Ishigami Japan 33 2.5k 1.9× 1.9k 1.5× 1.2k 1.4× 1.4k 2.1× 565 1.5× 278 4.7k
Mong Cho South Korea 30 861 0.6× 765 0.6× 717 0.8× 993 1.5× 385 1.0× 143 2.8k

Countries citing papers authored by Yoshiaki Katano

Since Specialization
Citations

This map shows the geographic impact of Yoshiaki Katano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiaki Katano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiaki Katano more than expected).

Fields of papers citing papers by Yoshiaki Katano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiaki Katano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiaki Katano. The network helps show where Yoshiaki Katano may publish in the future.

Co-authorship network of co-authors of Yoshiaki Katano

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiaki Katano. A scholar is included among the top collaborators of Yoshiaki Katano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiaki Katano. Yoshiaki Katano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Kazuhiko, Masatoshi Ishigami, Yoji Ishizu, et al.. (2018). Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy. Journal of Viral Hepatitis. 25(12). 1446–1451. 13 indexed citations
2.
Miyoshi, Hironao, et al.. (2016). Endoscopic Treatment for Pancreatolithiasis with a Novel Nitinol Basket Catheter. JOP, journal of the pancreas. 17(5). 1 indexed citations
3.
Honda, Takashi, Masatoshi Ishigami, Hiroko Masuda, et al.. (2014). Effect of peginterferon alfa‐2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology. 30(2). 321–328. 7 indexed citations
4.
Hayashi, Kazuhiko, Yoshiaki Katano, Yoji Ishizu, et al.. (2014). Association of interleukin 28 B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness. Journal of Gastroenterology and Hepatology. 30(1). 178–183. 8 indexed citations
6.
Hayashi, Kazuhiko, Masatoshi Ishigami, Yoshiaki Katano, et al.. (2013). Ursodeoxycholic acid inhibits overexpression of P-glycoprotein induced by doxorubicin in HepG2 cells. European Journal of Pharmacology. 724. 161–167. 18 indexed citations
7.
Toyoda, Hidenori, Takashi Kumada, Toshifumi Tada, et al.. (2011). Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b. Journal of Medical Virology. 84(1). 61–70. 6 indexed citations
8.
Arima, Yuko, Takuji Nakano, Naoto Kawabe, et al.. (2010). A case of erythropoietic protoporphyria with severe liver damage. Kanzo. 51(4). 175–182. 1 indexed citations
9.
Katano, Yoshiaki, Isao Nakano, Yoshiki Hirooka, et al.. (2010). Regulation of hepatic branched-chain α-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease. Biochemical and Biophysical Research Communications. 393(2). 303–307. 36 indexed citations
10.
Uchida, Hiroki, Yoshiki Hirooka, Akihiro Ito, et al.. (2009). Feasibility of tissue elastography using transcutaneous ultrasonography for the diagnosis of pancreatic diseases. Suizo. 24(4). 550–552. 4 indexed citations
11.
Hirooka, Yoshiki, Akihiro Ito, Hiroki Kawashima, et al.. (2009). A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Suizo. 24(5). 632–634. 72 indexed citations
12.
Suzuki, Fumitaka, Yoshiaki Katano, Michio Sata, et al.. (2008). Efficacy and safety of entecavir in lamivudine‐refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients. Journal of Gastroenterology and Hepatology. 23(9). 1320–1326. 46 indexed citations
13.
Ueyama, Jun, Ai Hattori, Yasuaki Tatsumi, et al.. (2008). Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells. Biochemical Pharmacology. 77(5). 858–866. 59 indexed citations
14.
Katano, Yoshiaki, Isao Nakano, Yoshiki Hirooka, et al.. (2007). Changes in circulating cytokine levels and lymphocyte subsets in healthy liver donors after partial hepatectomy. Hepatology Research. 37(10). 878–884. 4 indexed citations
15.
Shimizu, Yuko, Masahiko Yamada, Makoto Ishihara, et al.. (2006). Four cases of hepatitis E after eating wild boar meats in Aichi, Japan. Kanzo. 47(10). 465–473. 18 indexed citations
17.
Honda, Takashi, Yoshihide Fukuda, Isao Nakano, et al.. (2003). Effects of liver failure on branched-chain α-keto acid dehydrogenase complex in rat liver and muscle: comparison between acute and chronic liver failure. Journal of Hepatology. 40(3). 439–445. 26 indexed citations
18.
Nakano, Isao, Yoshihide Fukuda, Yoshiaki Katano, et al.. (2001). Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype. Gut. 49(2). 263–267. 9 indexed citations
19.
Hayashi, Kazuhiko, Yoshihide Fukuda, Isao Nakano, et al.. (2000). Poor response to interferon treatment for chronic hepatitis C in human immunodeficiency virus‐infected haemophiliacs. Haemophilia. 6(6). 677–681. 21 indexed citations
20.
Kumada, Takashi, Satoshi Nakano, Isao Takeda, et al.. (1990). Clinical usefullness of intraarterial infusion chemotherapy using implanted reservoir in patients with hepatic malignancies.. Kanzo. 31(1). 44–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026